Treatment with SMA inhibited A549 human lung cancer cell proliferation (Fig 1), and the IC50 value of SMA against serum- or GSK3β inhibitor-induced cancer cell proliferation was the lowest in A549 cells (Table 1). Here, SMN1 is linked to lung cancer.